European Commission grants conditional marketing authorization for Iqirvo® (elafibranor), first-in-class new treatment for primary biliary cholangitis (PBC), a rare liver diseaseApproval follows posit ...

Palvelussamme on juuri nyt häiriö, yritäthän myöhemmin uudelleen. Pahoittelemme aiheutunutta haittaa.

The liver function in post-cardiac arrest brain injury is not known and was investigated in a pig model of global cerebral ...

Report with the AI impact on market trends- The global ursodeoxycholic acid market size is estimated to grow by USD ...

Bile acids are essential signaling molecules derived from cholesterol metabolism in the liver and are crucial for the ...

July 25, 2024 — A new study brings researchers closer to better understanding the pathology of the fatty liver disease MASH, which stands for metabolic dysfunction-associated steatohepatitis.

(NASDAQ: MIRM) today announced that on September 10, 2024, the Compensation Committee of Mirum’s Board of Directors granted ...

At the Institute of Medicine, world-leading research is under way on some of the most common gastrointestinal and liver diseases. Our researchers investigate underlying disease mechanisms and various ...

Fatty liver disease is characterized by the presence of abnormal amounts of fat in the liver, which is called steatosis. If you have fat in your liver but no other damage, you are thought to have ...